Literature DB >> 30657544

MiR-219-5p promotes spinal cord injury recovery by inhibiting NEUROD2-regulated inflammation and oxidative stress.

Y Zhu1, Q Xu, W-P Sha, K-P Zhao, L-M Wang.   

Abstract

OBJECTIVE: The aim of this study was to explore the specific role of miR-219-5p in spinal cord injury (SCI), and to investigate its underlying mechanism.
MATERIALS AND METHODS: The SCI model was first constructed in mice, and the motor function of each mouse was evaluated by the Basso Beattie Bresnahan (BBB) method. The protein and mRNA expression levels of miR-219-5p and NEUROD2 in SCI mice were detected by Western blot and quantitative Real Time-Polymerase Chain Reaction (qRT-PCR), respectively. Subsequently, all mice were assigned into 3 groups, including the sham operation group, the SCI group and the SCI+miR-219-5p group. The levels of inflammatory factors (TNF-α, IL-1β and IL-6) were detected by Western blot and qRT-PCR. Meanwhile, reactive oxygen species (ROS) were detected by flow cytometry. Target genes of miR-219-5p were predicted by TargetScan and verified by Luciferase reporter gene assay. For in vitro experiments, the possible molecule mechanism of miR-219-5p in regulating NEUROD2 was detected by Western blot.
RESULTS: MiR-219-5p was significantly downregulated after SCI. The expression level of miR-219-5p was decreased in the SCI group than that of the sham operation group in a time-dependent manner, which reached the lowest level on the 7th day. Besides, the mRNA and protein levels of NEUROD2 in the SCI group were both remarkably increased in a time-dependent manner, which reached a peak on the 7th day. The levels of inflammatory factors (TNF-α, IL-1β and IL-6) and ROS were significantly higher in the SCI group, which could be reversed by miR-219-5p mimics transfection in SCI mice. Meanwhile, the BBB score in the SCI group was remarkably lower than that of the SCI + miR-219-5p group from the 4th day after SCI. TargetScan predicted that NEUROD2 was the target gene of miRNA-219-5p. In addition, Western blot results indicated that miR-219-5p could regulate NEUROD2, eventually promoting the recovery of SCI.
CONCLUSIONS: Overexpressed miR-219-5p promotes SCI recovery and motor function elevation via alleviating NEUROD2-regulated inflammation and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30657544     DOI: 10.26355/eurrev_201901_16745

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Extracellular vesicles derived from inflammatory-educated stem cells reverse brain inflammation-implication of miRNAs.

Authors:  Eleni Markoutsa; Karthick Mayilsamy; Dannielle Gulick; Shyam S Mohapatra; Subhra Mohapatra
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

2.  The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling.

Authors:  Swapna Mahurkar-Joshi; Carl Robert Rankin; Elizabeth Jane Videlock; Artin Soroosh; Abhishek Verma; Ariela Khandadash; Dimitrios Iliopoulos; Charalabos Pothoulakis; Emeran A Mayer; Lin Chang
Journal:  Gastroenterology       Date:  2021-02-20       Impact factor: 33.883

3.  Homoharringtonine Inhibits Allergic Inflammations by Regulating NF-κB-miR-183-5p-BTG1 Axis.

Authors:  Misun Kim; Hyein Jo; Yoojung Kwon; Youngmi Kim; Hyun Suk Jung; Dooil Jeoung
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

4.  MicroRNA-129-5p alleviates spinal cord injury in mice via suppressing the apoptosis and inflammatory response through HMGB1/TLR4/NF-κB pathway.

Authors:  Guang Wan; Yongbo An; Jingang Tao; Yanli Wang; Qinglan Zhou; Rongli Yang; Qiudong Liang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

5.  Circulating PAMM, a novel antioxidant and anti-inflammatory protein, is elevated in acute SCI.

Authors:  Leslie R Morse; Nguyen Nguyen; Yan Xu; Prakash Jha; Ricardo A Battaglino
Journal:  J Transl Med       Date:  2020-03-24       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.